A major bowel cancer trial is examining whether the test can show if surgery has removed all of the tumour. Dr Starling says the potential for this new technology across cancer care is "immense", not just when it comes to detecting residual disease after surgery, but also for early diagnosis. Blood tests are also being trialled to see if they can diagnose a whole range of cancers